Illumina bets on proteomics with $425m SomaLogic purchase
Acting CDER head becomes latest in string of FDA leaders to leave agency
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 28%
Roche's Hemlibra follow-up set for phase 3 in hemophilia A
*please scroll down for all the latest news *
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
Acting CDER head becomes latest in string of FDA leaders to leave agency
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 28%
Roche's Hemlibra follow-up set for phase 3 in hemophilia A
*please scroll down for all the latest news *
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud